![James D. Luterman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James D. Luterman
No más puestos en curso
Perfil
James D.
Luterman worked as the Executive Vice President-Research & Development at OvaScience, Inc. from 2016 to 2018.
He received his undergraduate degree from Bucknell University and his doctorate degree from Rutgers State University of New Jersey.
Antiguos cargos conocidos de James D. Luterman.
Empresas | Cargo | Fin |
---|---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | - |
Formación de James D. Luterman.
Bucknell University | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- James D. Luterman